Sara Bonstein is the CFO of Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. She has over 15 years of operational and financial leadership in the life sciences industry. Prior to joining Insmed, she served as the Chief Financial Officer, Chief Operating Officer, and Corporate Secretary at OncoSec Medical and as the Chief Financial Officer, Secretary, Treasurer, and Executive Vice President at Advaxis, Inc. Prior to these roles, Sara held several roles at Eli Lilly, ImClone, and Johnson & Johnson. In 2016, NJBiz named Sara CFO of the Year – Healthcare Organization and Forty under 40. Sara is a graduate of Johnson & Johnson’s Financial Leadership Development Program. She holds a BS in Finance from The College of New Jersey and an M.B.A. from Rider University.